Tengjun Biotechnology Corp. financial data

Location
Food Industry Economic And Technology, Development District, Jining, Shandong, China
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2023 - Aug 15, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Quick Ratio 0.89 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 101M shares +11.5%
Common Stock, Shares, Outstanding 101M shares +54.2%
Common Stock, Value, Issued 101K USD +54.2%
Weighted Average Number of Shares Outstanding, Basic 100M shares +53.4%
Weighted Average Number of Shares Outstanding, Diluted 100M shares +53.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 154M USD +98.8%
General and Administrative Expense 417K USD +55.2%
Operating Income (Loss) -428K USD -109%
Nonoperating Income (Expense) 7.42M USD +107%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -469K USD -110%
Income Tax Expense (Benefit) 2.9M USD -100%
Net Income (Loss) Attributable to Parent -453K USD -112%
Earnings Per Share, Basic 0 USD/shares -100%
Earnings Per Share, Diluted 0 USD/shares -100%

Balance Sheet

Label TTM Value / Value Unit Change %
Inventory, Net 2.35M USD +86%
Property, Plant and Equipment, Net 617K USD +27.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.3M USD -939%
Retained Earnings (Accumulated Deficit) 8.07M USD +747%
Stockholders' Equity Attributable to Parent 14.9M USD +684%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 15.3M USD +654%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 7.56M USD +500%
Net Cash Provided by (Used in) Financing Activities 2.02M USD +957%
Net Cash Provided by (Used in) Investing Activities -385K USD -694%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 101M shares +54.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9.18M USD +554%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 25.1M USD +271%
Deferred Tax Assets, Valuation Allowance 100K USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Depreciation 45.2K USD -46.3%
Payments to Acquire Property, Plant, and Equipment 77K USD +3129%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 5.04M USD +35.9%
Property, Plant and Equipment, Gross 1.92M USD +17.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Additional Paid in Capital 8.99M USD +717%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%